Gimoti Spray
NDC Package 72089-307-15

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Gimoti (metoclopramide hydrochloride) sprays is gIMOTI is indicated for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis. This formulation utilizes a spray delivery system. Marketed by Evoke Pharma, Inc., this product is identified by NDC 72089-307 and is authorized under FDA application NDA209388.

Identification & Billing

NDC Package Code
72089-307-15
Package Description
1 BOTTLE, PUMP in 1 CARTON / 9.8 mL in 1 BOTTLE, PUMP
Product Code
72089-307
11-Digit Billing Format
72089030715
RxNorm Crosswalk
  • RxCUI: 2380564 - metoclopramide 15 MG/ACTUAT Nasal Spray
  • RxCUI: 2380564 - metoclopramide 15 MG/ACTUAT (equivalent to 17.73 MG/ACTUAT of metoclopramide HCl) Nasal Spray
  • RxCUI: 2380570 - Gimoti 15 MG/ACTUAT Nasal Spray
  • RxCUI: 2380570 - metoclopramide 15 MG/ACTUAT Nasal Spray [Gimoti]
  • RxCUI: 2380570 - Gimoti 15 MG/ACTUAT (equivalent to 17.73 MG/ACTUAT of metoclopramide HCl) Nasal Spray

Clinical Specifications

Proprietary Name
Gimoti
Non-Proprietary Name
Metoclopramide Hydrochloride
Substance Name
Metoclopramide Hydrochloride
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Nasal - Administration to the nose; administered by way of the nose.
Active Ingredient(s)
METOCLOPRAMIDE HYDROCHLORIDE 15 mg/.07mL
Pharmacologic Class
Usage Information
GIMOTI is indicated for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis.

Regulatory & Marketing

Labeler Name
Evoke Pharma, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA209388
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-19-2020
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72089-307-15 identifies a specific commercial package of 1 bottle, pump in 1 carton / 9.8 ml in 1 bottle, pump of Gimoti, a human prescription drug labeled by Evoke Pharma, Inc.. This spray is formulated for nasal use and contains metoclopramide hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Evoke Pharma, Inc. on June 19, 2020. The current certification is valid through December 31, 2027.

How is this Evoke Pharma, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72089030715. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72089-307-15
11-Digit CMS (5-4-2)
72089-0307-15

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.